News
Samsung Biologics and Checkpoint Therapeutics Expand Manufacturing Partnership for...
Samsung Biologics Co., Ltd. and Checkpoint Therapeutics, Inc. announced the expansion of a long-term manufacturing partnership for Checkpoint’s anti-PD-L1 antibody, cosibelimab. Building upon an existing...
News
Wistar Scientists Creates a New Synthetic DNA Vaccine Against...
Scientists at The Wistar Institute have designed and tested the first-of-its-kind synthetic DNA vaccine against Powassan virus (POWV), targeting portions of the virus envelope protein....
News
Sanofi offers to acquire Kiadis, a clinical-stage company developing...
Sanofi and Kiadis, a clinical-stage biopharmaceutical company developing innovative ‘off the shelf’ natural killer (NK) cell based medicines for the treatment of life-threatening diseases, entered...
News
Global air cargo brand Turkish Cargo chosen as the...
Global air cargo brand Turkish Cargo chosen as the best air cargo brand of Europe The successful brand of national flag carrier Turkish Airlines, Turkish...
Clinical Trials
Novavax Provides Phase 3 COVID-19 Vaccine Clinical Development Update
Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced updates on its Phase 3 clinical development program of NVX-CoV2373, its...
Clinical Trials
Boehringer Ingelheim Begins Phase 2 Clinical Trial of a...
Boehringer Ingelheim announced the initiation of a Phase 2 clinical trial of BI 764198, an inhibitor of TRPC6, a receptor-operated cation channel. This potent and...
Drug Research
aTyr Pharma Announces Research Collaboration with Medical University of...
aTyr Pharma, Inc. , a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, announced that it has...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.